AMARIN CORP PLC\UK Investing Cash Flow
AMARIN CORP PLC\UK (AMRN) reported Investing Cash Flow of -$2.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-07-29
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $6.14M, a 50.54% decline year-over-year.
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$8.30M, a 168.78% decline year-over-year.
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$3.52M.
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$12.13M.
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities for fiscal 2025 was $8.83M.
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities for fiscal 2024 was -$45.98M.
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities for fiscal 2023 was -$25.52M, a 114.56% decline from fiscal 2022.
- AMARIN CORP PLC\UK net cash provided by (used in) investing activities for fiscal 2022 was $175.29M, a 68.38% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$2.16M 10-Q · filed 2026-07-29 | -$5.68M derived: sum of 3 quarters · filed 2026-07-29 | -$17.80M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$8.30M 10-Q · filed 2026-04-29 | -$11.81M derived: sum of 2 quarters · filed 2026-04-29 | -$23.94M derived: sum of 3 quarters · filed 2026-04-29 | -$11.53M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | -$3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$15.64M derived: sum of 2 quarters · filed 2026-03-02 | -$3.23M derived: sum of 3 quarters · filed 2026-07-29 | $8.83M 10-K · filed 2026-03-02 |
| 2025-09-30 | -$12.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $281.00K derived: sum of 2 quarters · filed 2026-07-29 | $12.35M 10-Q · filed 2025-10-29 | -$10.49M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $12.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $24.47M 10-Q · filed 2026-07-29 | $1.64M derived: sum of 3 quarters · filed 2026-07-29 | -$54.92M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $12.06M 10-Q · filed 2026-04-29 | -$10.78M derived: sum of 2 quarters · filed 2026-04-29 | -$67.33M derived: sum of 3 quarters · filed 2026-04-29 | -$62.63M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | -$22.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$79.39M derived: sum of 2 quarters · filed 2026-03-02 | -$74.69M derived: sum of 3 quarters · filed 2026-03-02 | -$45.98M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$56.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$51.86M derived: sum of 2 quarters · filed 2025-10-29 | -$23.14M 10-Q · filed 2025-10-29 | -$94.14M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $4.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $33.41M 10-Q · filed 2025-07-30 | -$37.59M derived: sum of 3 quarters · filed 2026-03-02 | -$6.82M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $28.72M 10-Q · filed 2025-05-07 | -$42.28M derived: sum of 2 quarters · filed 2026-03-02 | -$11.51M derived: sum of 3 quarters · filed 2026-03-02 | $22.81M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | -$71.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$40.23M derived: sum of 2 quarters · filed 2026-03-02 | -$5.91M derived: sum of 3 quarters · filed 2026-03-02 | -$25.52M 10-K · filed 2026-03-02 |
| 2023-09-30 | $30.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $65.09M derived: sum of 2 quarters · filed 2024-10-30 | $45.48M 10-Q · filed 2024-10-30 | $17.66M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-06-30 | $34.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $14.71M 10-Q · filed 2024-07-31 | -$13.11M derived: sum of 3 quarters · filed 2025-03-12 | $17.76M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-03-31 | -$19.61M 10-Q · filed 2024-05-01 | -$47.43M derived: sum of 2 quarters · filed 2025-03-12 | -$16.56M derived: sum of 3 quarters · filed 2025-03-12 | $56.63M derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | -$27.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $3.05M derived: sum of 2 quarters · filed 2025-03-12 | $76.24M derived: sum of 3 quarters · filed 2025-03-12 | $175.29M 10-K · filed 2025-03-12 |
| 2022-09-30 | $30.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $104.06M derived: sum of 2 quarters · filed 2023-11-01 | $203.11M 10-Q · filed 2023-11-01 | $228.12M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $73.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $172.24M 10-Q · filed 2023-08-02 | $197.25M derived: sum of 3 quarters · filed 2024-02-29 | $97.76M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $99.05M 10-Q · filed 2023-05-03 | $124.06M derived: sum of 2 quarters · filed 2024-02-29 | $24.57M derived: sum of 3 quarters · filed 2024-02-29 | $75.22M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $25.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$74.47M derived: sum of 2 quarters · filed 2024-02-29 | -$23.83M derived: sum of 3 quarters · filed 2024-02-29 | $104.10M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$99.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$48.84M derived: sum of 2 quarters · filed 2022-10-27 | $79.09M 10-Q · filed 2022-10-27 | $102.77M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $50.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $178.58M 10-Q · filed 2022-08-03 | $202.26M derived: sum of 3 quarters · filed 2023-03-01 | $197.91M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $127.93M 10-Q · filed 2022-05-04 | $151.62M derived: sum of 2 quarters · filed 2023-03-01 | $147.26M derived: sum of 3 quarters · filed 2023-03-01 | $44.79M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $23.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $19.33M derived: sum of 2 quarters · filed 2023-03-01 | -$83.14M derived: sum of 3 quarters · filed 2023-03-01 | -$376.96M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$4.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$106.83M derived: sum of 2 quarters · filed 2021-11-03 | -$400.65M 10-Q · filed 2021-11-03 | -$401.01M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$102.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$396.29M 10-Q · filed 2021-08-05 | -$396.65M derived: sum of 3 quarters · filed 2022-03-01 | -$397.97M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$293.82M 10-Q · filed 2021-04-29 | -$294.19M derived: sum of 2 quarters · filed 2022-03-01 | -$295.50M derived: sum of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | -$364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$1.68M derived: sum of 2 quarters · filed 2022-03-01 | -$2.48M 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$2.11M 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | -$801.00K 10-Q · filed 2020-08-04 | |||
| 2018-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$58.00K 10-K · filed 2021-02-25 | ||
| 2018-09-30 | -$53.00K 10-Q · filed 2019-11-05 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | -$12.00K 10-K · filed 2020-02-25 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$12.00K 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | -$12.00K 10-Q · filed 2018-08-01 | |||
| 2016-12-31 | -$21.00K 10-K · filed 2019-02-27 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $0.00 derived: sum of 2 quarters · filed 2014-02-27 | $0.00 derived: sum of 3 quarters · filed 2014-02-27 | -$14.00K 10-K · filed 2014-02-27 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | -$14.00K 10-Q · filed 2013-11-07 | -$12.64M derived: sum of 4 quarters · filed 2014-02-27 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$14.00K 10-Q · filed 2013-08-08 | -$12.64M derived: sum of 3 quarters · filed 2014-02-27 | -$13.27M derived: sum of 4 quarters · filed 2014-02-27 |
| 2013-03-31 | -$14.00K 10-Q · filed 2013-05-09 | -$12.64M derived: sum of 2 quarters · filed 2014-02-27 | -$13.27M derived: sum of 3 quarters · filed 2014-02-27 | -$14.26M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-12-31 | -$12.63M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$13.25M derived: sum of 2 quarters · filed 2014-02-27 | -$14.25M derived: sum of 3 quarters · filed 2014-02-27 | -$14.34M 10-K · filed 2014-02-27 |
| 2012-09-30 | -$626.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$1.62M derived: sum of 2 quarters · filed 2013-11-07 | -$1.72M 10-Q · filed 2013-11-07 | -$2.08M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | -$997.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$1.09M 10-Q · filed 2013-08-08 | -$1.45M derived: sum of 3 quarters · filed 2014-02-27 | -$3.13M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | -$92.00K 10-Q · filed 2013-05-09 | -$457.00K derived: sum of 2 quarters · filed 2014-02-27 | -$2.13M derived: sum of 3 quarters · filed 2014-02-27 | |
| 2011-12-31 | -$365.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$2.04M derived: sum of 2 quarters · filed 2014-02-27 | -$2.05M 10-K · filed 2014-02-27 | |
| 2011-09-30 | -$1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$1.68M 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | -$9.00K 10-Q · filed 2012-08-08 | |||
| 2010-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $1.00K derived: sum of 2 quarters · filed 2013-02-28 | -$23.00K 10-K · filed 2013-02-28 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$24.00K 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | -$24.00K 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $584.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |